Cargando…
Exploring the Protective Efficacy of Topical Products for Actinic Keratosis Against Ultraviolet-Induced DNA and Protein Damage: An Experimental, Double-Blind Irradiation Study
Introduction Numerous studies have delved into the clinical efficacy of different topical treatments for actinic keratosis (AK). However, our understanding remains limited regarding their capacity to prevent DNA and protein damage caused by ultraviolet radiation (UVR). Objectives The aim of this stu...
Autores principales: | Minoretti, Piercarlo, Emanuele, Enzo, García Martín, Ángel, Liaño Riera, Miryam, Gómez Serrano, Manuel, Santiago Sáez, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517867/ https://www.ncbi.nlm.nih.gov/pubmed/37746407 http://dx.doi.org/10.7759/cureus.44065 |
Ejemplares similares
-
Evaluating the Serum Levels of Beclin-1 and Mammalian/Mechanistic Target of Rapamycin (mTOR) in Three Different Professional Categories
por: Minoretti, Piercarlo, et al.
Publicado: (2023) -
Mild Depressive Symptoms in Airline Pilots Associated With Impaired Executive Functions
por: Minoretti, Piercarlo, et al.
Publicado: (2023) -
Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma
por: Abudu, Boya, et al.
Publicado: (2019) -
Circumscribed Palmar Hypokeratosis With Superimposed Actinic Keratosis
por: Aukerman, Erica, et al.
Publicado: (2023) -
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A(2) inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial
por: Ortner, Vinzent Kevin, et al.
Publicado: (2022)